PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33507976-8	2021	Ceftriaxone administration in epileptic animals led to a reduction of glutamate along with elevation of the level of glutamine synthetase activity and GLT-1 expression in the acute phase.	Ceftriaxone	0-11	glutamate-ammonia ligase	Homo sapiens	117-137	
20423712-7	2010	Furthermore, inhibition of ceftriaxone-mediated increased glutamine synthetase activity by dihydrokainate (DHK), a GLT-1 specific inhibitor, confirms the specific effect of ceftriaxone on GLT-1 activity.	Ceftriaxone	27-38	glutamate-ammonia ligase	Homo sapiens	58-78	
20423712-7	2010	Furthermore, inhibition of ceftriaxone-mediated increased glutamine synthetase activity by dihydrokainate (DHK), a GLT-1 specific inhibitor, confirms the specific effect of ceftriaxone on GLT-1 activity.	Ceftriaxone	173-184	glutamate-ammonia ligase	Homo sapiens	58-78